title: Rivaroxaban induced liver injury: A cholestatic pattern.
authors.affiliation: Department of Hypertension, Vascular Disease and Clinical Pharmacology, Strasbourg Regional University Hospital, France.
authors.forename: Mihaela
authors.initials: M
authors.lastname: Cordeanu
authors.affiliation: Department of Hypertension, Vascular Disease and Clinical Pharmacology, Strasbourg Regional University Hospital, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Gaertner
authors.affiliation: Department of Vascular Medicine, General Hospital Mulhouse, France.
authors.forename: Naouel
authors.initials: N
authors.lastname: Bensalah
authors.affiliation: Department of Hypertension, Vascular Disease and Clinical Pharmacology, Strasbourg Regional University Hospital, France.
authors.forename: Corina
authors.initials: C
authors.lastname: Mirea
authors.affiliation: Department of Vascular Medicine, General Hospital Mulhouse, France.
authors.forename: Amer
authors.initials: A
authors.lastname: Hamade
authors.affiliation: Department of Hypertension, Vascular Disease and Clinical Pharmacology, Strasbourg Regional University Hospital, France; Regional Pharmacovigilance Centre, Strasbourg Regional University Hospital, France. Electronic address: dominique.stephan@chru-strasbourg.fr.
authors.forename: Dominique
authors.initials: D
authors.lastname: Stephan
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D000072226:Computed Tomography Angiography; D019468:Disease Management; D005260:Female; D006801:Humans; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000069552:Rivaroxaban / Q000009:adverse effects*
chemical_list: D000069552:Rivaroxaban
keywords: Direct oral anticoagulant; Drug-induced liver injury; Hepatotoxicity; RUCAM; Rivaroxaban; Venous thromboembolism